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The innate immune system is an ancient and diverse collection of defenses, including the recognition of pathogens
through the use of germline-encoded pathogen receptors. The adaptive immune system, encompassing T and B
cell responses, is a more recent development that utilizes somatically recombined antigen receptor genes to
recognize virtually any antigen. The adaptive immune system has the advantage of ﬂexibility and immunologic
memory but it is completely dependent upon elements of the innate immune system for the initiation and direction
of responses. Appropriate innate and acquired immune system interactions lead to highly efﬁcient recognition and
clearance of pathogens, but maladaptive interactions between these two systems can result in harmful immuno-
logic responses including allergy, autoimmunity, and allograft rejection.
Key words: innate immunity/adaptive immunity/skin
J Invest Dermatol 125: 629–637, 2005
Immunologic defenses in vertebrates consist of two immu-
nologic subsystems—innate and adaptive. For much of the
past 30 years, immunologists and microbiologists have
studied innate and adaptive immunity in isolation. Today,
these elements of immunity are appreciated as obligate and
synergistic parts of the system that mediate successful host
responses to infection and tissue injury. The innate immune
system encompasses a collection of host defenses that
range from the non-specific barrier function of epithelia to
the highly selective recognition of pathogens through the
use of germline-encoded receptors. A common feature of
these diverse elements is a rapid and blunt response to
infection or tissue destruction (Janeway and Medzhitov,
2002). In contrast, the adaptive immune system uses so-
matically rearranged antigen receptor genes to create re-
ceptors for virtually any antigen. The adaptive immune
response is slower but more flexible and is able to combat
infections that have evolved to evade innate responses. The
adaptive immune system has the capacity to recognize and
respond to virtually any protein or carbohydrate imaginable;
yet, without the innate immune system to instruct it—in
effect, telling it whether, when, how, and where to re-
spond—it is powerless. The mechanisms by which the in-
nate immune system instructs and directs adaptive immune
responses are becoming increasingly clear and what
follows is a discussion of this immunologic interface.
The Innate Immune System: Rapid Response
The innate immune system responds by recognition of con-
served motifs in pathogens as well as a number of other
indicators of cell stress or death. The cellular components
of the innate immune system include dendritic cells, mon-
ocytes, macrophages, granulocytes, and natural killer T
cells, as well as the skin, pulmonary, and gut epithelial cells
that form the interface between an organism and its envi-
ronment. The non-cellular aspects of the innate system are
diverse and range, from the simple barrier function of the
stratum corneum to complex pathways such as the com-
plement cascade. These non-cellular elements seek to pre-
vent the entry of pathogens through physical blockade, or
once invaded, to destroy pathogens directly or call them to
the attention of phagocytes. This review will focus primarily
on innate immune elements that are known to interface with
the adaptive immune system.
The innate immune system has evolved to recognize
molecular patterns common to many classes of pathogens;
these elements have been termed pathogen-associated
molecular patterns (PAMP). PAMP are diverse and include
lipopolysaccharides (LPS), aldehyde-derivatized proteins,
mannans, teichoic acids, denatured DNA, and bacterial
DNA (Medzhitov and Janeway, 2002). The innate immune
system recognizes PAMP using a group of germline-coded,
evolutionary conserved proteins termed pathogen-recogni-
tion receptors (PRR) (Janeway and Medzhitov, 2002). PRR
were initially defined as cell-surface pathogen receptors
present on innate immune cells, but this definition has been
expanded to include secreted and locally produced mole-
cules that mediate many steps in inflammation including
directed phagocytosis, activation of inflammatory signaling
pathways, induction of cell death, and activation of
the complement or coagulation cascades (Janeway and
Medzhitov, 2002).
The Toll-like receptors (TLR) are a particularly important
group of pathogen receptors. These molecules are ex-
pressed on both innate immune cells and on cells in various
tissues including endothelial cells, epithelial cells, and fib-
roblasts (Schnare et al, 2001; Janeway and Medzhitov,
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2002). Ten TLR family members specific for various micro-
bial molecules have been identified in humans. Binding of
TLR to their microbial ligands leads to activation of
phagocytes and direct killing of pathogens, as well as to
the release of pro-inflammatory cytokines and anti-micro-
bial peptides (Takeda et al, 2003). In addition, these mol-
ecules activate dendritic cells and are therefore important in
the initiation of adaptive immune responses, a role that will
be discussed more fully below. Binding of ligands to TLR
triggers activation of the nuclear factor-kB (NF-kB) signaling
pathway (Takeda et al, 2003). This signaling pathway is a
master switch for the induction of inflammation. In the skin,
NF-kB signaling induces the expression of chemokines,
cytokines, adhesion molecules, matrix metalloproteases,
nitric oxide synthase, and enzymes that regulate prostanoid
synthesis, in short, everything needed to instigate an in-
flammatory response (Medzhitov and Janeway, 1997).
In addition to TLR, other types of tissue factors associ-
ated with inflammation can act as danger signals leading to
the activation of phagocytes and dendritic cells (Matzinger,
2002; Kapsenberg, 2003). These factors include heat-shock
proteins, lectins, cytokines, chemokines, extracellular ma-
trix components, and various cell-surface molecules in-
cluding lipids from necrotic cells. These danger signals lead
to phagocyte activation and destruction of endocytosed
pathogens as well as activation of dendritic cells and the
resultant initiation of adaptive immune responses.
Anti-microbial proteins and peptides are additional com-
ponents of the innate immune system. These molecules in-
clude large proteins such as lysozyme and cathepsin G as
well as smaller anti-microbial peptides including the defen-
sins, cathelicidins, and the skin anti-microbials dermcidin
and psoriasin (Madsen et al, 1991; Schittek et al, 2001;
Ganz, 2003). Mice deficient for cathelicidin are susceptible
to infections with Group A Streptococcus, demonstrating
the importance of these molecules (Nizet et al, 2001). The
defensin family of peptides has anti-microbial effects at
physiologic concentrations and is produced by a variety of
cell types including neutrophils and epithelial cells of the
epidermis, bronchial tree, and genitourinary tract. Defensins
kill pathogens directly through cell lysis and can also induce
the chemotaxis of monocytes, dendritic cells, and T cells.
For example, the defensin hBD-2 binds to the CCR6
chemokine receptor and is chemotactic for both immature
dendritic cells and memory T cells (Yang et al, 1999). This is
a notable example of a molecule, microbicidal in its own
right, that also signals to key elements of both the innate
and adaptive immune systems.
Anti-microbial peptides have particular clinical relevance
in dermatology. It has long been observed that patients with
psoriasis, a chronic inflammatory and hyperproliferative skin
disorder, suffer from fewer skin infections than would be
expected, given the degree of skin barrier disruption. It was
recently reported that psoriatic scales contain high levels of
anti-microbial peptides including defensins, psoriasin, and
additional novel compounds (Harder and Schroder, 2005).
The anti-microbial psoriasin, first isolated from psoriatic
epidermis (Madsen et al, 1991), protects human skin from
Escherichia coli infection (Glaser et al, 2005). The high levels
of microbicidal peptides in psoriatic skin may underlie its
relative resistance to bacterial superinfection. In contrast,
skin affected by atopic dermatitis is notoriously susceptible
to infections with Gram-positive bacteria and has also
been found to lack expression of the important anti-
microbial proteins cathelicidin and the defensin hBD-2
(Ong et al, 2002).
The Adaptive Immune System: Flexible
but Dependent
T and B lymphocytes are the cellular elements of the adap-
tive immune system, a relatively recent evolutionary devel-
opment dating back to the emergence of vertebrates some
400 million years ago. The hallmarks of the adaptive im-
mune response are flexibility and memory. Flexibility is pro-
vided by the unique way in which T and B cells recognize
antigens. Unlike cells in the innate system, which use a fixed
repertoire of inherited receptors, T and B cells undergo a
recombination of antigen receptor genes to create novel
and unique antigen receptors capable of recognizing virtu-
ally any antigen. B and T cells that have encountered
antigen persist over the long term within an organism and
provide rapid and specific responses to reinfection, a con-
cept known as immunologic memory.
Antibodies, encoded by heavy and light immunoglobulin
(Ig) genes, are the antigen receptors on B cells. Antibodies
can be both cell surface bound and secreted and are clas-
sified by the isotype of their heavy chains (IgM, IgG, IgE,
IgA). Antibodies recognize the tertiary (three dimensional)
structure of native proteins and glycoproteins. B cells first
produce pentameric IgM but under the influence of T cell
cytokines and other factors, B cells undergo additional ge-
netic recombination events leading to isotype switching and
production of IgG subtypes, IgE or IgA. Fine tuning of an-
tigen specificity is also accomplished by affinity maturation.
This process involves hypermutation of antibody genes
combined with competition for antigen within lymphoid fol-
licles, leading to selective survival of B cells with the highest
affinity for antigen.
T cell receptors differ from B cell receptors in several
fundamental ways. First, they are never secreted, existing
instead on the cell surface as heterodimers of ab or gd
subunits. Second, T cells recognize peptides produced by
the proteolytic cleavage of antigens as opposed to the na-
tive proteins recognized by B cells. Thus, T cells recognize
the primary structure (amino acid sequence), and B cells
recognize the tertiary (three-dimensional folded) structure of
a protein. Lastly, T cells recognize antigenic peptides only
when they are presented on the cell surface bound to class I
or class II major histocompatibility (MHC) proteins .
Cellular cross-talk is a hallmark of the adaptive immune
system. In order for naı¨ve B cells to proliferate and differ-
entiate in response to most antigens, they must be stim-
ulated by a CD4þ helper T cell that is specific for the same
antigen. T cells also require a second signal in order to
proliferate and differentiate after encountering antigen. T
cells that do not receive this co-signal are likely to be ren-
dered unresponsive, or anergic. Thus, T cells determine
what B cell antigens will be recognized, and T cells need
another signal in order to proliferate in response to antigen,
a signal that can be provided by B cells. B and T cells
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therefore engage in a complex dialog during immune re-
sponses.
T cells can be divided into a number of distinctive sub-
sets based on their migration patterns and functional abil-
ities. Naı¨ve T cells recirculate primarily between the blood
and lymph nodes, a pattern aided by their expression of the
homing receptors L-selectin and CCR7 (Mackay et al, 1990;
Sallusto et al, 1999). This allows them to sample the
environments of lymph nodes from different tissue
types, increasing their chances of encountering specific
antigen. Memory T cells can be further divided into central
memory and effector memory cells (Sallusto et al, 2004).
Central memory Tcells primarily migrate between blood and
lymph nodes in a pattern similar to that of naı¨ve T cells,
although recent evidence suggests that these cells may
also enter peripheral tissues (Campbell et al, 2001). Central
memory T cells serve primarily as long-lived reservoirs of
immunologic memory. When stimulated with antigen, these
cells give rise to additional central memory cells as well
as effector memory T cells. Effector memory T cells are
shorter lived and aggressive, specialized for migration
into target tissues and neutralization of pathogens (Sallusto
et al, 2004).
Memory T cells can also be characterized based on what
peripheral tissues they enter. The body can be subdivided
into different immunologic zones, and T cells that encounter
antigen first in a particular tissue tend to recirculate through
that tissue in the future (Campbell and Butcher, 2002; Kup-
per and Fuhlbrigge, 2004). This tissue-specific migration is
controlled by the expression of specific molecules, termed
homing receptors, on the surface of memory T cells. Ex-
pression of the homing receptor cutaneous lymphocyte
antigen guides T cells to the skin, and expression of the
integrin a4b7 sends T cells specifically to the gut (Picker
et al, 1990; Butcher et al, 1999). This selective recirculation
to the sites of prior antigen exposure allows T cells to focus
their attention on sites where this antigen is most likely to be
encountered in the future.
Lastly, CD4þ T helper cells can be functionally divided
into Th1-, Th2-, and T-regulatory (Treg) cells. Th1 cells se-
crete Th1 cytokines including IFN-g and TNF-b and are ef-
ficient at activating macrophages and stimulating cytotoxic
T cells, thereby inducing what is termed cell-mediated im-
munity. Th2 T cells secrete Th2 cytokines such as interleukin
(IL)-4, IL-5, and IL-13, and are efficient at stimulating B cells
to make antibodies, in particular IgE, inducing what is called
the humoral immune response (Mosmann and Coffman,
1989). The immune response to a pathogen can be primarily
cellular or humoral, based on the particular response of an
individual. In general, Th1 cytokines encourage cellular im-
munity and can suppress Th2 responses. A notable excep-
tion is the finding that the Th1 cytokine IFN-g acts to induce
B cell production of IgG2a antibodies, a subtype implicated
in Th2 autoimmune diseases including lupus (Gavalchin
et al, 1987; Snapper and Paul, 1987). Similarly, Th2
cytokines activate humoral responses and can act to sup-
press cellular responses. Treg cells are a recently recog-
nized family of CD4þ T cells that act to suppress the
responses of other T cells. These cells play a role in reg-
ulating self-tolerance but may also interfere with immunity
to tumors (Sakaguchi et al, 2001).
In summary, T cells can be considered to be ‘‘polarized’’
in a number of different ways. Memory T cells are spatially
polarized in that they migrate to specific tissues based on
where they first encountered antigen. Secondly, helper T
cells are functionally polarized in that they encourage dif-
ferent types of immunity: cellular immunity, humoral immu-
nity, or no immunity (tolerance). Lastly, memory T cells are
both spatially and functionally polarized by whether they
migrate primarily to lymph nodes and promote memory re-
sponses (central memory T cells) or migrate to peripheral
tissues and promote destruction of pathogens (effector
memory T cells). These T cell polarization states help to fine
tune and regulate the adaptive immune response. Most, if
not all, of these polarization states are the direct result of
signaling from the innate immune system through its inter-
mediate cell, the dendritic cell.
Dendritic Cells: The Bridge Between
Old and New
Dendritic cells are members of the innate immune system
that are particularly efficient at stimulating T cells to respond
to antigen (Banchereau and Steinman, 1998). Dendritic cells
are the only cells capable of activating naı¨ve T cells, and
they can load endocytosed antigenic peptides on both
MHC class I and MHC class II molecules, allowing presen-
tation to both CD8 and CD4 T cells (Rescigno et al, 1998;
Guermonprez et al, 2003). Dendritic cells develop in the
bone marrow and migrate to the tissues in an immature
form. Immature dendritic cells efficiently take up antigens
from the environment but they do not provide T cell co-
stimulatory signals and are therefore poor activators of T
cells. Dendritic cells undergo maturation when they are ex-
posed to a number of danger signals including the PAMP
described above as well as various cytokines and tissue
factors (Chain, 2003). Upregulation of co-stimulatory
molecules occurs during maturation with the result that
mature dendritic cells are extremely potent activators of
T cell responses.
Dendritic cells detect danger signals within the tissues
and transmit this information to T cells. Pathogens and tis-
sue insults of many kinds are translated into a common
result—activation and maturation of dendritic cells through
the NF-kB signaling pathway. It is now becoming recog-
nized that dendritic cells pass on a remarkable amount of
information to T cells about the type of insult that prompted
their maturation (Kapsenberg, 2003). This information af-
fects whether a T cell will respond to antigen, how it will
respond, and likely where it will go to respond. The signals
that mediate this rich communication are only partially es-
tablished, and the discussion below will focus on what is
currently known about this process.
Dendritic cells provide a number of sequential signals to
responding Tcells. The first signal consists of the interaction
of the T cell receptor with specific antigen and MHC on the
surface of the dendritic cell and determines the antigen
specificity of the response. The second signal provides the
co-signaling that T cells need in order to respond to antigen.
This co-signaling can be either positive (co-stimulation) or
negative (co-inhibition) and can be provided by a growing
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family of molecules including CD80 (B7-1), CD86 (B7-2),
CD28, and CTLA-4 (Baxter and Hodgkin, 2002; Chen,
2004). In the absence of a second signal or in the presence
of a co-inhibitory signal, T cells fail to respond to antigen
and may in fact be rendered unresponsive to this antigen in
the future (Fig 1A). Thus, the second signal answers the
question ‘‘will I respond?’’ The third signal delivered by the
dendritic cell stimulates CD4þ T cells to develop into Th1,
Th2, or Treg T cells (Fig 1B). This third signal determines the
functional polarization of these cells and answers the ques-
tion ‘‘how will I respond?’’ Lastly, T cells receive poorly
characterized signals from either dendritic cells or their en-
vironment, which stimulate them to produce homing recep-
tors that will direct them to migrate through tissues similar
to those in which they first encountered antigen (Campbell
and Butcher, 2002) (Fig 1C). This fourth signal determines
spatial polarization and answers the question ‘‘where do I
go to respond?’’ As our knowledge about the complexities
of lymphocyte behavior expands, additional signals that fine
tune T cell responses will likely be discovered.
Co-signaling (the second signal) is delivered by dendritic
cells that have undergone activation and maturation in re-
sponse to the detection of danger signals in the environ-
ment. These signals, described above, are diverse but
generally have activation of the NF-kB pathway in common
(Bonizzi and Karin, 2004). In most cases, activation of den-
dritic cells leads to maturation but there are certain
immunosuppressive drugs and microbial compounds that
arrest dendritic cells in an immature state, preventing them
from expressing co-stimulatory molecules. These dendritic
cells are unable to stimulate lymphocytes fully and may in
fact induce tolerance through anergy or production of Treg
cells (Kapsenberg, 2003). For example, Plasmodium falc-
iparum infects red blood cells and these infected cells par-
alyze dendritic cells by binding to CD36 and CD52 (Urban
and Roberts, 2002). Thus, although the innate immune sys-
tem is efficient at perceiving a variety of danger signals and
translating these into T cell responses via dendritic cell
maturation, there are a number of pathogens that have
evolved to evade this response.
Functional polarization of T cells by dendritic cells (the
third signal) is a remarkable story that continues to unfold.
Different PAMP and danger signals appear to polarize den-
dritic cells functionally into Th1-, Th2-, or Treg-type cells,
imprinting them with the ability to produce cytokines and
to induce T cells to differentiate selectively into Th1, Th2, or
Treg cells. PAMP and other danger signals can thus be di-
vided into type 1, type 2, and regulatory-type PAMP that
induce the formation of Th1, Th2, and Treg cells, respec-
tively. Dendritic cells subsets appear to be flexible in that
they can adopt any polarization state, although rare sub-
types may be hardwired to produce Treg cells (Bilsborough
et al, 2003). Thus, dendritic cells tell T cells not only to re-
spond but also how to respond, tipping them off as to the
type of immune response that should be initiated.
Type 1 PAMP have been most fully studied and include
many but not all of the TLR. For example, double-stranded
RNA binds to the TLR3 (Alexopoulou et al, 2001) and in-
duces the maturation of dendritic cells that strongly support
the formation of Th1 T cells (Cella et al, 1999; de Jong et al,
2002). LPS binding to TLR4 induces IL-12 production in
dendritic cells as well as the ability to induce a Th1 phe-
notype in T cells in both mice and humans (Langenkamp
et al, 2000; Boonstra et al, 2003). But not all TLR-associated
signals produce type 1 dendritic cells. Mycoplasma-derived
lipopeptide 2 binding to TLR2–TLR6 heterodimers induces
dendritic cells to secrete IL-10, not IL-12, and these
dendritic cells induce unpolarized T cell responses
(Weigt et al, 2003). Moreover, TLR2 triggering by the lys-
ophosphatidylserine from the parasite Schistosoma man-
soni actually stimulates dendritic cells to secrete the
regulatory cytokine IL-10 and induces T cells to adopt a
Treg phenotype (van der Kleij et al, 2002).
Th2-biased host responses are often involved in the
effective control of infections with parasitic worms. This
Th2 bias may arise from the ability of parasitic antigens to
induce the formation of type 2 dendritic cells. ES-62, a
glycoprotein isolated from the filarial nematode Acantho-
cheilonema viteae, induces the formation of type 2 dendritic
cells that support the selective development of Th2 T cells
(Whelan et al, 2000). Soluble extracts from the eggs of S.
mansoni induce the development of type 2 dendritic cells
that support Th2 T cell development both in vitro and in vivo
(MacDonald et al, 2001; de Jong et al, 2002). PRR that can
mediate induction of type 2 dendritic cells have yet to be
identified, although there is some evidence for the contri-
bution of TLR4 signaling through a pathway independent of
myeloid differentiation factor 88 (Kaisho et al, 2002).
An increasing number of pathogens are being identified
that can induce the formation of regulatory dendritic cells,
which in turn support the development of regulatory T cells.
Priming with the filamentous hemagglutinin of Bordatella
pertussis and lysophosphatidylserine from S. mansoni, both
ligands for the TLR2, induces the formation of regulatory
dendritic cells that impose a T-regulatory phenotype on in-
teracting Tcells (McGuirk et al, 2002; van der Kleij et al, 2002).
The mechanisms for the spatial polarization of T cells (the
fourth signal) are only beginning to be identified. When T
cells are primed by dendritic cells located in the gut-asso-
ciated lymph nodes, these cells upregulate gut-homing ad-
hesion molecules that will preferentially send them back to
this tissue in the future (Campbell and Butcher, 2002). This
spatial imprinting was recently shown to be the result of
retinoic acid production by gut-associated dendritic cells
during T cell priming (Iwata et al, 2004). Moreover, only gut-
associated dendritic cells produce retinoic acid; skin-asso-
ciated dendritic cells must use a different signal to imprint T
cells with skin-homing ability. Deciphering these molecular
signals is particularly important for the development of vac-
cines that will send T cells specifically to the tissues most at
risk for infection.
In summary, dendritic cells provide at least three addi-
tional signals to T cells that allow them to fine tune their
responses. Information is given on whether or not to re-
spond, how to respond (Th1, Th2, and Treg) and where
to respond (selective homing). The innate immune system
therefore plays a very active role in supporting T cell re-
sponses. Additional signals are likely to be discovered as
these interactions are explored more fully.
The innate immune system also has the ability to modify
the tolerance of T cells to antigen. Most self-reactive T cells
are deleted in the thymus during T cell development but
632 CLARK AND KUPPER THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Response:
T cell activation
No response
Dendritic cell
CD80/CD86
CD80/CD86
TCR Signal 1
Signal2: Co-stimulation
Signal2:
Co-inhibition
CD28
CTLA-4
Peptide–MHC
class II Naive TH cell
TH1-polarizing
factor(IL-12, IL27)
TH2-polarizing
factor (CCL2)
Treg-polarizing
factor (IL-10, TGF-β)
TH1
TH2
Treg
TH1-regulatory
polarizing
signal 3
signal 3
TH2-polarizing
TH1-polarizing
signal 3
Signal 2
Signal 1
PRR
PRR
PRR
Dendritic cell
TCR
CD28
Type1
PAMPs/ TFs
CCR5 ligand
IFN-γ
IFN-α
IL-18 IFN-γ
TNF-β
IL-10
TGF-β
IL-4
IL-5
IL-13
IL-10
TGF-βCCR2 ligandhistamine
PGE2
TSLP
Type2
PAMPs/TFs
Regulatory
PAMPs/TFs
Peptide–MHC
class II
Naive TH cell
CLA−, α4β7+
CCR9+
CLA+, α4β7−
CCR4+or
CCR10+
Intestinal
dendritic cell
Skin
dendritic cell
Peptide–MHC class II
Peptide–MHC class II
Gut-homing
T cell
Skin-homing
T cell
Naive TH cell
Skin homing polarizing signal
(and absence of retinoic acid)
Retinoic acid
TCR
TCR
Naive TH cell
(A)
(B)
(C)
Figure 1
T cell stimulation and polarization require four signals from dendritic cells. (A) Signal one determines antigen specificity and consists of
interaction of the T cell receptor (TCR) with peptides loaded onto dendritic cell major histocompatibility (MHC) molecules. Signal two consists of co-
signaling and can be either positive, leading to cell activation (co-stimulation) or negative, leading to no response (co-inhibition). Co-signaling
molecules, including CD80 and CD86, are upregulated on dendritic cells after binding of pathogen-associated molecular patterns (PAMP) to their
cognate receptors. (B) Signal three involves the polarization of CD4 T cells into either Th1, Th2, or regulatory T cells. Immature dendritic cells are
polarized by the binding of type 1, type 2, or regulatory PAMP and differentiate into mature dendritic cells that induce the formation of Th1, Th2, or T
regulatory T cells, respectively. In general, viral-associated PAMP give rise to Th1 responses, and PAMP from parasitic organisms favor Th2
responses. (C) Signal four leads to spatial imprinting of T cells, leading to the acquisition of homing receptors that induce selective recirculation
through the tissue in which antigen was first encountered. Dendritic cells from the intestine uniquely produce retinoic acid, inducing T cells to
upregulate the T cell gut-homing receptors a4b7 and CCR9 and suppress expression of the skin-homing receptor cutaneous lymphocyte antigen
(CLA). Signals that polarize T cells to migrate to other sites, including the skin, brain, and pulmonary epithelia, have yet to be identified.
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some survive and enter the peripheral circulation. These
auto-reactive T cells are controlled by a number of mech-
anisms that are together termed peripheral tolerance. The
innate immune system influences peripheral tolerance at
several points. First, dendritic cells that have not received a
danger signal present antigen to T cells in the absence of
co-signaling molecules. In the absence of co-stimulation or
in the presence of co-inhibition, T cells can be functionally
silenced and rendered unresponsive to antigens in the fu-
ture (Baxter and Hodgkin, 2002; Chen, 2004). Second, den-
dritic cells can induce the formation of Treg cells that can
suppress other T cell responses, as discussed above. Last-
ly, the innate immune system can function to inhibit toler-
ance by overruling the action of established Treg cells.
Dendritic cells triggered by particular TLR can produce IL-6
and other cytokines that render T helper cells resistant to
suppression by Treg cells (Kaisho et al, 2001; Pasare and
Medzhitov, 2003). The innate immune system can therefore
function to both induce and suppress tolerance.
Dendritic cells are the main envoys between the innate
and adaptive immune system but there are situations when
other elements of the innate response signal directly to T
cells. For example, some anti-microbial peptides and pro-
teins, including the defensin hBD-2, are chemotactic for T
cells (Yang et al, 1999). Interestingly, several platelet
chemokines, including CXCL4 (PF-4), CCL5 (RANTES), and
CTAP-3, also have anti-microbial activity, suggesting that the
anti-microbial peptide and chemokine families may func-
tionally overlap (Durr and Peschel, 2002; Tang et al, 2002).
Dialogue between the innate and adaptive immune sys-
tems is not one sided. Elements of the adaptive response
also support the function of the innate immune system. For
example, antibodies secreted by B cells bind to macroph-
ages and other phagocytes by interaction with Fc receptors
on these cells. Phagocytes can efficiently recognize, inter-
nalize, and destroy pathogens using these borrowed anti-
bodies. Moreover, this selective internalization enhances
the ability of these cells to internalize and present these
antigens to T cells, thereby boosting acquired responses.
Immunity in the Skin: Adaptive and
Maladaptive
To examine the interactions of the innate and acquired im-
mune systems in the context of cutaneous immunity, it is
helpful to consider clinical situations that highlight both the
positive and negative effects of these systems.
First, we will consider a response of the skin to infection
with a bacterial pathogen. As illustrated in Fig 2, bacteria
gain access to the body through a break in the skin, thereby
overcoming the innate system’s first line of defense: an in-
tact stratum corneum. In response to this invasion, keratin-
ocytes produce increased levels of cytokines, chemokines,
and microbicidal peptides, including the chemotactic de-
fensins. These peptides have four key effects. First, they
help to control the infection by direct killing of the pathogen.
Second, they are chemotactic for the cellular elements of
Bacterial pathogen
Antimicrobial peptides, 
chemokines and cytokines Dendritic cell endocytosis
and activation via TLRs
Phagocyte endocytosis
and killing of pathogen
Antibody mediated
• pathogen neutralization
• complement activation
• enhanced endocytosis by phagocytes
Chemokine/cytokine mediated
• activation of dermal endothelium
• increased extravasation of leukocytes
• chemotaxis of T cells and innate leukocytes
Migration to skin 
draining lymph nodes
T cell activation
and polarization
Provision of
B cell help
Lymph node
Peptide-MHC Naïve T cell
TCR
Memory 
T cell
Memory CD8 T cell
cytotoxic killing
Memory skin-homing
T cell
B cell Memory CD4 
T cellB cell
Figure 2
Interactions between the innate and acquired immune systems in response to bacterial infection of the skin. In response to bacteria that
have breached the epithelial barrier, keratinocytes synthesize anti-microbial peptides, chemokines, and cytokines. These factors lead to activation of
the dermal endothelium, inducing the migration of innate leukocytes and memory T cells into the skin and additionally guiding these cells via
chemotactic gradients. These factors and bacterial antigens activate innate phagocytes to kill ingested organisms and activate dendritic cells to
migrate to the skin-homing lymph nodes. In the lymph nodes, dendritic cells present bacterial antigens to naı¨ve and central memory T cells, leading
to stimulation of pathogen-specific cells. Effector CD8 cells exit the lymph node, home to inflamed skin and kill pathogens. Helper CD4 T cells
provide help to B cells, inducing the production of antibodies that directly neutralize pathogens and lead to additional targeting of innate responses.
Antibody-directed phagocytosis by innate cells leads to enhanced antigen presentation, further enhancing acquired responses.
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the innate immune system, including phagocytes and den-
dritic cells. Third, these peptides signal directly to the
adaptive immune response by causing chemotaxis of mem-
ory T cells. Lastly, these factors lead to activation of the
dermal endothelium and increased expression of E-selectin
and other vascular adhesion molecules. This leads to in-
creased entry of both innate immune cells and skin-homing
memory T cells into the inflamed area of skin. Phagocytes
and dendritic cells next arrive and begin to engulf the path-
ogens. Activation of innate system phagocytes leads to
triggering of the respiratory burst and killing of engulfed or-
ganisms, whereas activation of dendritic cells induces them
to flee the scene, carrying with them the antigenic peptides
they have collected. Dendritic cells enter the draining lymph
nodes and present the antigens they have acquired to naı¨ve
and central memory T cells. During this crucial transfer of
information, T cells are tipped off as to the type of immune
response to initiate (Th1 vs Th2 vs Treg) and where to initiate
it (acquisition of addressins leading to selective homing). T
cells specific for pathogen-associated antigens then prolif-
erate, giving rise to CD4þ T helper cells and CD8þ cyto-
toxic killer T cells. CD8þ T cells enter the circulation,
home to the inflamed skin, and directly destroy pathogens.
Meanwhile, pathogen-specific CD4þ cells within lymph
nodes provide and to B cells, inducing the production of
pathogen-specific antibodies. These antibodies can directly
neutralize the pathogen by binding to its surface but can
also destroy pathogens via two key interactions with the
innate immune system. Firstly, antibodies bound to patho-
gens can initiate the complement cascade, leading to lysis
of the pathogen and further enhanced phagocytosis of the
organism by the deposition of complement-derived opson-
ins. Secondly, antibodies can bind to innate system
phagocytes via interaction with Fc receptors. This leads to
one of the most daunting collaborations of the innate and
acquired immune systems, a phagocyte loaded with mi-
crobicidal enzymes and bristling with pathogen-specific
antibodies. In addition to direct killing of pathogens, these
borrowed antibodies lead to enhanced phagocytosis
and highly efficient antigen presentation to T cells, leading
to increased adaptive T cell responses. These collabora-
tions of the innate and acquired immune systems lead
to multiple levels of defense, ideally leading to clearance of
the pathogen.
Adaptive immune responses provide the key elements of
specificity and memory but they also carry a risk of inducing
maladaptive immune responses including autoimmunity, al-
lergy, and allograft rejection. These conditions occur when
the immune system responds to non-pathogenic antigens
as if they were infectious. Invertebrates and plants, which
lack adaptive immune systems, show no evidence of these
maladaptive immune responses (Janeway and Medzhitov,
2002). Interactions between the innate and adaptive im-
mune systems are crucial for these processes; innate ele-
ments are responsible for labeling a particular antigen as
‘‘dangerous’’ and passing this information on to the adap-
tive immune response. T and B cells then initiate a full but
misdirected immune response, leading to harmful inflam-
mation. Examples include the immune responses against
pancreatic beta cells in diabetes and against melanocytes
in vitiligo.
Atopic diseases, including atopic dermatitis, asthma,
and seasonal rhinitis, are also the products of maladaptive
innate and adaptive immune interactions. Genetic poly-
morphisms in genes involved in innate immune activation
have been associated with an increased incidence of atopic
diseases. Allelic forms of CD14, which serves as a receptor
for bacterial cell wall components including endotoxin and
LPS, have been associated with altered susceptibilities to
atopic diseases. The 159 C to T polymorphism correlates
with increased levels of serum IgE in atopic children (Baldini
et al, 1999). Interestingly, this polymorphism correlates with
early-onset atopy only during the childhood years, and a
second study has confirmed that this polymorphism is not
associated with asthma in an adult population (O’Donnell
et al, 2004; Kedda et al, 2005). This CD14 polymorphism is
also associated with an increased risk of non-atopic asthma
and food allergies (Woo et al, 2003). Polymorphisms in the
TLR may also contribute to atopy. Polymorphisms in TLR2
are associated with an increased incidence of asthma, al-
lergic rhinitis, and atopic sensitization among children living
on farms, and variations in TLR4 correlate with the severity
of asthma (Eder et al, 2004). Lastly, polymorphisms in the
cytokines macrophage migration-inhibitory factor and mon-
ocyte chemoattractant protein 1 as well as the intracellular
LPS receptor caspase recruitment domain containing pro-
tein 15 are all associated with an increased susceptibility to
atopic diseases (Kabesch et al, 2003; Hizawa et al, 2004;
Yao et al, 2004). In addition to their participation in atopy,
autoimmunity, and transplant rejection, exaggerated innate
immune responses associated with high levels of inflam-
matory cytokines can lead acutely to hyperthermia and or-
gan failure, and chronic exposure can lead to the formation
of chronic inflammatory states (Kobayashi and Flavell,
2004).
Conclusions
Recent advances in understanding of the innate and adap-
tive immune responses have shown that these two systems,
previously studied in isolation, are intricately intertwined.
Dendritic cells form the chief interface between the innate
and adaptive immune systems. These cells convey at least
four signals to T cells that lead to modifications of adaptive
immune responses. As information continues to emerge
about the interdependence of these two systems, it seems
somewhat artificial to consider them as separate entities.
These two elements may be better visualized as two mu-
tually supportive subsystems, each providing information
and assistance to the other. Although imperfect, it is a sys-
tem that provides a remarkable degree of flexibility and re-
sponsiveness, providing the best possible defense against
a changing world.
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